Hyperkalemic Periodic Paralysis
Learn what the condition is, how it may be detected early, how it is treated or managed, and which breeds or species are linked to it.
Condition snapshot
A concise guide to the condition’s pattern, detection, management and urgency.
Breeding advice appliesUse the screening guidance and veterinary or genetics advice before breeding an affected or at-risk animal.
Emergency presentation is possibleBreathing noise, obstruction or collapse during an attack requires emergency veterinary care.
This snapshot is a general guide, not a diagnosis or treatment plan. New, severe or worsening signs require veterinary assessment.
About the condition
Hyperkalemic periodic paralysis, or HYPP, is an inherited muscle sodium-channel disorder caused by a mutation in SCN4A. It traces to the Quarter Horse stallion Impressive and occurs in related Quarter Horses, Paints, Appaloosas and crosses. The autosomal dominant mutation makes muscle membranes intermittently overexcitable when blood potassium changes; horses with one or two copies can be affected, with two-copy animals generally at greater risk.
Episodes range from subtle muscle fasciculation, sweating, yawning and third-eyelid prolapse to weakness, dog-sitting, collapse and inability to breathe. Horses usually remain alert. Some attacks follow high-potassium feed, fasting followed by a meal, transport, stress, anaesthesia or rest after exercise, but an episode can occur without an obvious trigger. Between attacks the horse may look completely normal and athletic.
HYPP differs from exertional rhabdomyolysis because muscle pain and large CK increases are not typical. It also differs from ordinary dietary hyperkalaemia: affected channels respond abnormally to potassium shifts that healthy horses tolerate. Sudden death can occur from respiratory muscle paralysis or cardiac arrhythmia.
The mutation does not disappear with careful feeding. Management lowers episode frequency but cannot change genetic status or guarantee safety. Because inheritance is dominant and clinical severity is unpredictable, affected horses should not be used for breeding. Breed-registry rules vary, but welfare-based genetic counselling should not depend only on whether a particular horse has yet shown obvious attacks.
HYPP results from a dominant SCN4A variant descending from the Quarter Horse stallion Impressive. Abnormal muscle sodium channels permit episodes of fasciculation, weakness, prolapse of the third eyelid, collapse or noisy breathing. Potassium can be normal between attacks, and some homozygous horses are more severely affected than heterozygotes.
Respiratory obstruction during a severe attack can turn an episodic muscle disorder into an immediate fatal emergency.
Screening & Early Detection
A DNA test on mane or tail roots with follicles, or blood, identifies normal, heterozygous and homozygous SCN4A status. Testing through an accredited laboratory is definitive for the known mutation and should verify the horse’s identity when used for breeding or sale. Descendants of Impressive with unknown status should not be assumed clear from appearance.
During an episode, blood potassium may be high, normal or already falling, so one normal result does not exclude HYPP. Electrocardiography identifies potassium-related rhythm change, and CK helps distinguish rhabdomyolysis. The veterinarian observes muscle fasciculation, third-eyelid movement, swallowing and breathing while minimising stress.
Choke, botulism, colic, seizures and other causes of weakness or collapse remain differentials. Anaesthetic planning requires HYPP status because fasting, fluids and recovery can provoke episodes, and malignant hyperthermia susceptibility may coexist in some lines. Owners should log time, feed, exercise and stress around attacks to identify individual triggers. Increasing frequency, breathing noise or collapse warrants urgent reassessment even when previous episodes resolved spontaneously.
Treatment & Management
A mild episode may resolve with calm handling and light movement if the horse is stable and able to walk safely. Veterinary treatment can include oral glucose or corn syrup to stimulate insulin-mediated potassium movement into cells, or intravenous glucose and insulin with close monitoring in more serious cases. Calcium can stabilise cardiac membranes, and a diuretic may assist selected horses. Severe respiratory obstruction may require emergency airway support.
For long-term control, total dietary potassium is kept low and consistent using analysed forage. Grass hay is generally preferable to lucerne and high-potassium feeds; soaking can reduce potassium but changes other nutrients. Meals are small and frequent to avoid fasting and large shifts. Regular turnout and steady exercise help, while sudden stress and abrupt ration changes are minimised.
Acetazolamide or hydrochlorothiazide can reduce attacks in some horses under veterinary supervision, with hydration and electrolytes monitored. Pre-anaesthetic plans avoid prolonged fasting and use appropriate fluids and recovery observation. Every carer should know the emergency signs and genetic status. Management can be very effective for some heterozygotes, but horses with repeated collapse, airway compromise or two mutation copies carry greater risk. Affected horses are excluded from breeding to prevent transmission.
Breeds or species affected
American Quarter Horse
Open horse breed description, care requirements and conditions
American Paint Horse
Open horse breed description, care requirements and conditions
Appaloosa
Open horse breed description, care requirements and conditions
Quarter Pony
Open horse breed description, care requirements and conditions